APAndré Pawlak

André Pawlak

*This is an algorithmically generated author record based on publicly available information.

André Pawlak has a total of 188 co-authors. Here are the top co-authors by number of shared publications:

  • Djillali Sahali

    Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France

    17 shared publications
  • Vincent Audard

    Department of Nephrology and Renal Transplantation

    14 shared publications
  • Philippe Lang

    INSERM U955, équipe 21 Assistance publique - Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor - Université Paris-Est Créteil Val-de-Marne - Paris 12 - Institut National de la Santé et de la Recherche Médicale - U955Université Paris-Est Créteil Val-de-Marne - Paris 12 - IFR10

    10 shared publications
  • Mario Ollero

    Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France

    8 shared publications
  • Shao-Yu Zhang

    UPEC (Université Paris Est Créteil), INSERM (Institut National de la Santé et de la Recherche Médicale) U955, Institut Mondor de Recherche Biomédicale (IMRB), Equipe 21, Créteil, France

    8 shared publications
  • Georges Guellaën

    INSERM, U 955, Equipe 21, Créteil, France

    7 shared publications

Latest Publications

  • Open Access

    Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis

    by Cerina Chhuon, Luis Vicente Herrera-Marcos, Shao-Yu Zhang, Cécile Charrière-Bertrand, Vincent Jung, Joanna Lipecka, Berkan Savas, Nour Nasser, André Pawlak, Hocine Boulmerka, et al.

    Focal and segmental glomerulosclerosis (FSGS) is a severe form of idiopathic nephrotic syndrome (INS), a glomerulopathy of presumably immune origin that is attributed to extrarenal pathogenic circulating factors. The recurrence of FSGS (rFSGS) after transplant occurs in 30% to 50% of cases. The direct analysis of patient plasma proteome has scarcely been addressed to date, mainly due to the methodological difficulties associated with plasma complexity and dynamic range. In this study, first, we compared different methods of plasma preparation, second, we compared the plasma proteomes of rFSGS and controls using two preparation methods, and third, we analyzed the early proximal signaling events in podocytes subjected to patient plasma, through a combination of phosphoproteomics and lipid-raft proteomics (raftomics). By combining immunodepletion and high pH fractionation, we performed a differential proteomic analysis of soluble plasma proteins and of extracellular vesicles (EV) obtained from healthy controls, non-INS patient controls, and rFSGS patients (n = 4). In both the soluble- and the EV-protein sets from the rFSGS patients, we found a statistically significant increase in a cluster of proteins involved in neutrophil degranulation. A group of lipid-binding proteins, generally associated with lipoproteins, was found to be decreased in the soluble set from the rFSGS patients. In addition, three amino acid transporters involved in mTORC1 activation were found to be significantly increased in the EV from the rFSGS. Next, we incubated human podocytes for 30 min with 10% plasma from both groups of patients. The phosphoproteomics and raftomics of the podocytes revealed profound differences in the proteins involved in the mTOR pathway, in autophagy, and in cytoskeleton organization. We analyzed the correlation between the abundance of plasma and plasma-regulated podocyte proteins. The observed changes highlight some of the mechanisms involved in FSGS recurrence and could be used as specific early markers of circulating-factor activity in podocytes.


  • CMIP is a negative regulator of T cell signaling

    by Julie Oniszczuk, Kelhia Sendeyo, Cerina Chhuon, Berkan Savas, Etienne Cogné, Pauline Vachin, Carole Henique, Ida Chiara Guerrera, Giuseppe Astarita, Vincent Frontera, et al.

    Upon their interaction with cognate antigen, T cells integrate different extracellular and intracellular signals involving basal and induced protein-protein interactions, as well as the binding of proteins to lipids, which can lead to either cell activation or inhibition. Here, we show that the selective T cell expression of CMIP, a new adapter protein, by targeted transgenesis drives T cells toward a naïve phenotype. We found that CMIP inhibits activation of the Src kinases Fyn and Lck after CD3/CD28 costimulation and the subsequent localization of Fyn and Lck to LRs. Video microscopy analysis showed that CMIP blocks the recruitment of LAT and the lipid raft marker cholera toxin B at the site of TCR engagement. Proteomic analysis identified several protein clusters differentially modulated by CMIP and, notably, Cofilin-1, which is inactivated in CMIP-expressing T cells. Moreover, transgenic T cells exhibited the downregulation of GM3 synthase, a key enzyme involved in the biosynthesis of gangliosides. These results suggest that CMIP negatively impacts proximal signaling and cytoskeletal rearrangement and defines a new mechanism for the negative regulation of T cells that could be a therapeutic target.


  • Cationic poly(cyclodextrin)/alginate nanocapsules: From design to application as efficient delivery vehicle of 4-hydroxy tamoxifen to podocyte in vitro

    by Sabrina Belbekhouche, Julie Oniszczuk, André Pawlak, Imane El Joukhar, Angélique Goffin, Gilles Varrault, Dil Sahali, Benjamin Carbonnier


  • Open Access

    Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis

    by Khedidja Bouachi, Anissa Moktefi, Shao-Yu Zhang, Julie Oniszczuk, Kelhia Sendeyo, Philippe Remy, Vincent Audard, Andre Pawlak, Mario Ollero, Djillali Sahali

    Lupus glomerulopathies are classified into various histological patterns, which probably result from different pathophysiological origins. Podocyte injury can be demonstrated in lupus nephritis but its clinical relevance is far little appreciated and is often masked by proliferative lesions and inflammatory cell infiltrations. Two patterns of podocyte lesions may be considered, either occurring in the context of renal inflammation or reflecting podocyte dysfunction in non-proliferative and non-inflammatory glomerulopathies. This distinction remains elusive since no reliable biomarker discriminates between both entities. CMIP was recently found induced in some glomerular disease but its expression in different lupus nephritis classes has not been investigated. Twenty-four adult patients with lupus nephritis, including non-proliferative (n = 11) and proliferative (n = 13) glomerulopathies were analyzed. Clinical, biological and immunological data were compared with immunomorphological findings. We analyzed by quantitative and qualitative methods the expression of CMIP in different histological classes. We found CMIP abundance selectively increased in podocytes in class II and class V glomerulopathies, while in proliferative forms (class III and class IV), CMIP was rarely detected. CMIP was not expressed in cellular crescents, endothelial cells or mesangial cells. CMIP colocalized with some subsets of B and T cells within glomerular or interstitial mononuclear cell infiltrates but never with macrophages. Hematuria is rarely present in lupus glomerulopathies expressing CMIP. There was no correlation between classical immunological markers and CMIP expression. Thus, CMIP induction in lupus nephritis seems restricted to non-proliferative glomerulopathies and may define a specific pattern of podocyte injury.


  • NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome

    by Ahmed Boumediene, Pauline Vachin, Kelhia Sendeyo, Julie Oniszczuk, Shao-Yu Zhang, Carole Henique, Andre Pawlak, Vincent Audard, Mario Ollero, Vincent Guigonis, et al.


  • Repression of CMIP transcription by WT1 is relevant to podocyte health

    by Anissa Moktefi, Shao-Yu Zhang, Pauline Vachin, Virginie Ory, Carole Henique, Vincent Audard, Catherine Rucker-Martin, Elodie Gouadon, Michael Eccles, Andreas Schedl, et al.


  • Immunopathogenesis of idiopathic nephrotic syndrome with relapse

    by Djillali Sahali, Kelhia Sendeyo, Melanie Mangier, Vincent Audard, Shao Yu Zhang, Philippe Lang, Mario Ollero, Andre Pawlak

    Idiopathic change nephrotic syndrome (INS), the most frequent glomerular disease in children and young adults, is characterized by heavy proteinuria and a relapsing remitting course. Although the mechanisms underlying the pathophysiology of proteinuria remain unclear, clinical and experimental observations suggest that lymphocyte and podocyte disturbances are two sides of the disease. The current hypothesis suggests that immune cells release a putative factor, which alters podocyte function resulting in nephrotic proteinuria. Besides T-cell abnormalities, recent evidence of B-cell depletion efficacy in sustained remissions added a new challenge in understanding the immunological mechanisms of INS. In this review, we discuss recent insights related to podocyte disorders occurring in INS and their relevance in human diseases.


  • Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

    by Hassan Izzedine, Melanie Mangier, Virginie Ory, Shao-Yu Zhang, Kelhia Sendeyo, Khedidja Bouachi, Vincent Audard, Christine Péchoux, Jean C. Soria, Christophe Massard, et al.


  • Open Access

    Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy

    by Kelhia Sendeyo, Vincent Audard, Shao-Yu Zhang, Qingfeng Fan, Khedidja Bouachi, Mario Ollero, Catherine Rucker-Martin, Elodie Gouadon, Dominique Desvaux, Franck Bridoux, et al.


  • c-mip Down-Regulates NF-κB Activity and Promotes Apoptosis in Podocytes

    by Virginie Ory, Qingfeng Fan, Nabila Hamdaoui, Shao-Yu Zhang, Dominique Desvaux, Vincent Audard, Marina Candelier, Laure-Helene Noel, Philippe Lang, Georges Guellaën, et al.